Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Olga Saric"'
Autor:
Massimo Fantini, Justin M. David, Olga Saric, Alexander Dubeykovskiy, Yongzhi Cui, Sharon A. Mavroukakis, Andrew Bristol, Christina M. Annunziata, Kwong Y. Tsang, Philip M. Arlen
Publikováno v:
Frontiers in Immunology, Vol 8 (2018)
NEO-201 is a novel humanized IgG1 monoclonal antibody that was derived from an immunogenic preparation of tumor-associated antigens from pooled allogeneic colon tumor tissue extracts. It was found to react against a variety of cultured human carcinom
Externí odkaz:
https://doaj.org/article/c1fc282fdae44cc7933f1278a62417db
Autor:
Olga Saric, Philip M. Arlen, Ernesto P. Molmenti, Myron Arlen, A Dubokouvskiy, Kwong-Yok Tsang, XuePing Wang, Conte C, Gene F. Coppa
Publikováno v:
Madridge Journal of Vaccines. 1:27-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::726e79710dbcb5c2cc13dda04c7146c6
https://doi.org/10.18689/mjv-1000107
https://doi.org/10.18689/mjv-1000107
Autor:
XuePing Wang, John A. Procaccino, Philip M. Arlen, John S. Sullivan, A Dubokouvskiy, Olga Saric, Myron Arlen, Jim Crawford, Gene F. Coppa, Gary B. Deutsch, Ernesto P. Molmenti
Publikováno v:
Madridge Journal of Vaccines. 1:9-13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b8c14daf653c74fd0cc707ae5e94039
https://doi.org/10.18689/mjv-1000103
https://doi.org/10.18689/mjv-1000103
Autor:
Coppa G, Conte C, A. Doubakovski, Olga Saric, A. Kadison, Myron Arlen, James Sullivan, Philip M. Arlen, Jeffrey Crawford, E Molmenti, XuePing Wang, J. Procaccino, J. Bandovic
Publikováno v:
Journal of Cancer
With the ability to identify the presence of transforming colonocytes in a field adjacent to an existing primary colon cancer, it is now possible to reduce if not eliminate one of the major causes leading to anastomotic tumor recurrence. In a review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f65a729442bbebab8c9bebcd96f28a2
http://europepmc.org/articles/PMC4216803
http://europepmc.org/articles/PMC4216803
Autor:
Philip M. Arlen, J. Procaccino, Ernesto P. Molmenti, James Sullivan, Olga Saric, Myron Arlen, Jeffrey Crawford, X. Wang, Conte C, A. Doubakovski, A. Kadison, Gene F. Coppa, J. Bandovic
Publikováno v:
International Journal of Surgery. 54:303-304
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78c066bc6c3d85a133398ccc5b4d6cc5
https://doi.org/10.1016/j.ijsu.2018.02.012
https://doi.org/10.1016/j.ijsu.2018.02.012
Autor:
Philip M. Arlen, Sandip Pravin Patel, XuePing Wang, Michael A. Morse, Andrew Bristol, Olga Saric, Alex Dubeykovskiy
Publikováno v:
Cancer Immunology, Immunotherapy. 62:1011-1019
NPC-1C is a chimeric immunoglobulin IgG1 developed from antigen tested in the Hollinshead tumor vaccine trials that recognizes an immunogenic MUC5AC-related tumor-associated antigen. In this article, we describe the pre-clinical characterization of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f12d54c0ff5a68190e46dd4b1d17f43
https://doi.org/10.1007/s00262-013-1420-z
https://doi.org/10.1007/s00262-013-1420-z
Publikováno v:
Journal of Cancer
The ability to define malignancy in its earliest stages of development is an essential part of any program aimed at attempting to cure the malignant condition. In terms of colon cancer various approaches have been employed to define the transformatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71d7c77139786b063b6fbf54832d6755
https://doi.org/10.7150/jca.5468
https://doi.org/10.7150/jca.5468
Publikováno v:
Current Drug Delivery. 9:52-56
Tumor associated antigens from pooled allogeneic membrane proteins were isolated, partially purified and tested as a possible vaccine in patients with stage II and III colon cancer. The vaccine, when given in combination with an adjuvant following su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd0acc948cf5dde5189aa625fee02c77
https://doi.org/10.2174/156720112798376087
https://doi.org/10.2174/156720112798376087
Autor:
Ernesto P. Molmenti, Philip Arlen, XuePing Wang, Olga Saric, Myron Arlen, Jim Crawford, Gene F. Coppa, Alex Dubeykovskiy
In an attempt to improve upon the end results obtained in treating colorectal cancer it was apparent that the earlier the diagnosis that could be obtained, the better the chance for obtaining desired results. In the case of more advanced tumors typif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b2f660d34029720746ea53531983da
https://europepmc.org/articles/PMC4058724/
https://europepmc.org/articles/PMC4058724/
Autor:
Lidia Hernandez, Alex Dubeykovskiy, Christina M. Annunziata, Monica K. Neuman, Philip M. Arlen, Olga Saric, XuePing Wang
Publikováno v:
Cancer Research. 76:1496-1496
Objectives: Given the heterogeneity of ovarian cancer, it is imperative to identify subtype-directed treatments. The novel antibody NEO-201 targets a specific tumor-associated antigen (TAA) expressed on some ovarian and uterine malignancies, providin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::082bacf3b3bb9fad73eb4d2fdf042ad3
https://doi.org/10.1158/1538-7445.am2016-1496
https://doi.org/10.1158/1538-7445.am2016-1496